Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab Before Second Allogeneic Transplantation. // Transplantation and Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S2666636726004860?dgcid=rss_sd_all
Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab Before Second Allogeneic Transplantation. Transplantation and Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S2666636726004860?dgcid=rss_sd_all
“Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab Before Second Allogeneic Transplantation.” Transplantation and Cellular Therapy.
@article{article148850,
title = {Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab Before Second Allogeneic Transplantation},
journal = {Transplantation and Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S2666636726004860?dgcid=rss_sd_all}
}